Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Duration (3-day vs 8-day) in CAP
NCT01963442Phase 2Unknown
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Nov 2013
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin + clavulanate in community acquired pneumonia (CAP), sponsored by Centre Hospitalier de Versailles. Status: unknown.
02
Drugs
amoxicillin + clavulanate
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01963442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963442.